What is the CVR number of Evosep Biolabs ApS?

Evosep Biolabs ApS is registered with CVR / Virk under CVR 44216701.

What is the revenue of Evosep Biolabs ApS?

Evosep Biolabs ApS reported revenue of DKK -3,6M in 2025.

Who is the CEO of Evosep Biolabs ApS?

Morten Bern is Management of Evosep Biolabs ApS, in role since 2023.

Where is Evosep Biolabs ApS headquartered?

Evosep Biolabs ApS's registered address is Billedskærervej 15.

Evosep Biolabs ApS

APSActive

CVR 44216701Billedskærervej 15Research and experimental development on natural sciences and engineering · NACE 7210Est. 2023— employees

Full Risika report

Revenue 2025

DKK -3,6M

+29% vs 2024

EBITDA margin

100.0%

-29% vs 2024

Equity ratio

100.0%

Financial strength

Net profit 2025

DKK -4M

-34% vs 2024

EBITDA — year on yearDKK millions

Key figuresAnnual report 2025

Revenue	DKK -3,6M	+29%
EBITDA	DKK -3,6M	-29%
Net profit	DKK -4M	-34%
Total assets	DKK 701K	-52%
Equity	DKK 701K	+124%
Employees	—	—

Item	2024	2025
Revenue	-2.808	-3.615
Staff expenses	-0	-0
EBITDA	-2.808	-3.615
Depreciation & amort.	-45	-84
EBIT	-2.853	-3.699
Net financials	-93	-262
Profit before tax	-2.946	-3.961
Tax	-0	-0
Net profit	-2.946	-3.961

Item	2024	2025
Total assets	1.462	701
Equity	-2.906	701
Long-term debt	0	0
Short-term debt	4.368	0
Total debt	4.368	0

Name	Role	Member since	Age	Other directorships
MB Morten Bern Management	Management	2023	—	—
OV Ole Vorm Management	Management	2023	—	—
JB Jens Bornhøft Christensen Management	Management	2025	—	—
CR Christian Ravnsborg Management	Management	2023	—	—

Shareholder	Type	Ownership	Votes	Since
Evosep ApS	Company	100.0%	100.0%	2023

Person	Role here	Other companies
Morten Bern	Management	0 companies
Ole Vorm	Management	0 companies
Jens Bornhøft Christensen	Management	0 companies
Christian Ravnsborg	Management	0 companies

Evosep Biolabs ApS

APSActive

CVR 44216701Billedskærervej 15Research and experimental development on natural sciences and engineering · NACE 7210Est. 2023— employees

Full Risika report

Revenue 2025

DKK -3,6M

+29% vs 2024

EBITDA margin

100.0%

-29% vs 2024

Equity ratio

100.0%

Financial strength

Net profit 2025

DKK -4M

-34% vs 2024

EBITDA — year on yearDKK millions

Key figuresAnnual report 2025

Revenue	DKK -3,6M	+29%
EBITDA	DKK -3,6M	-29%
Net profit	DKK -4M	-34%
Total assets	DKK 701K	-52%
Equity	DKK 701K	+124%
Employees	—	—